Category Public Health:

Ozempic and Fat Futurity

Posted on by Evangelia Kindinger

A year ago, I first came across the term “Ozempic Face” in various social media posts and celebrity reporting. The Ozempic Face is, so the complaint, recognizable by sagging facial skin and other signs of ageing – effects of the weight loss caused by the intake of the drug. Semaglutide, sold under the brand name Ozempic, is a drug that lowers blood sugar levels and was initially meant to treat type 2 diabetes, but is now also used for weight loss. Ozempic particularly gained prominence in 2023, when more and more celebrities were rumored to have lost a conspicuous amount of weight in a short period of time – with resulting shortages in supply left people with diabetes struggling to get access. The Ozempic Face is a…

» Read More

Fat Bias and the Development of Clinical Protocols in Brazil

Posted on by Lisa Moura

Brazil is a huge, diverse country with significant social disparities. People are commonly judged and stigmatized due to their social class, race, education, gender, and body characteristics. Weight, particularly high weight, is one of the body characteristics that is used to stigmatize parts of the population, often intersecting with race and class. Similar to other parts of the world, the fat body in Brazil is seen as synonymous with ‘failure,’ ‘lack of control,’ ‘laziness,’ and ‘ignorance.’ Low-income classes believe that weight gain is related to heredity or stress, while high-income classes, especially those who are not fat, blame ‘poor’ diet and exercise choices. In reaction to this last point, the Brazilian government has propagated strategies to combat weight gain based on self-control, seeking…

» Read More